Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ
出版年份 2015 全文链接
标题
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume 26, Issue 4, Pages 682-687
出版商
Oxford University Press (OUP)
发表日期
2015-01-20
DOI
10.1093/annonc/mdv013
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- International variation in management of screen-detected ductal carcinoma in situ of the breast
- (2014) Antonio Ponti et al. EUROPEAN JOURNAL OF CANCER
- Molecular profiling of breast ductal carcinoma in-situ
- (2014) Emmanuel Agosto-Arroyo et al. PATHOLOGY
- Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype
- (2013) M Lazzeroni et al. BRITISH JOURNAL OF CANCER
- Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events
- (2013) E. Karlsson et al. EUROPEAN JOURNAL OF CANCER
- Variation in detection of ductal carcinoma in situ during screening mammography: A survey within the International Cancer Screening Network
- (2013) Elsebeth Lynge et al. EUROPEAN JOURNAL OF CANCER
- HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ
- (2012) E Rakovitch et al. BRITISH JOURNAL OF CANCER
- Lapatinib Activity in Premalignant Lesions and HER-2-Positive Cancer of the Breast in a Randomized, Placebo-Controlled Presurgical Trial
- (2011) A. DeCensi et al. Cancer Prevention Research
- Targeting the HER/EGFR/ErbB Family to Prevent Breast Cancer
- (2011) L. R. Howe et al. Cancer Prevention Research
- The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive disease
- (2011) Shuko Harada et al. JOURNAL OF SURGICAL ONCOLOGY
- Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast
- (2010) Henry M. Kuerer et al. CANCER
- Current perspectives of treatment of ductal carcinoma in situ
- (2010) Laura G. Estévez et al. CANCER TREATMENT REVIEWS
- Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis
- (2010) K. Kerlikowske et al. JNCI-Journal of the National Cancer Institute
- HER2-positive status is an independent predictor for coexisting invasion of ductal carcinoma in situ of the breast presenting extensive DCIS component
- (2010) Ning Liao et al. PATHOLOGY RESEARCH AND PRACTICE
- HER-2/neu Overexpression as a Predictor for the Transition from In situ to Invasive Breast Cancer
- (2009) R. E. Roses et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation